IMC Chicago
GPCR icon

IMC Chicago’s Structure Therapeutics GPCR Stock Holding History

IMC Chicago’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$988K Buy
+18,400
New +$814K ﹤0.01% 3874

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

IMC Chicago's GPCR Position: Q2 2026 in Review

IMC Chicago opened a new position in Structure Therapeutics (GPCR) in Q2 2026: 8,618 shares worth $463K. The stake represents ﹤0.01% of the portfolio and ranks #4740 among its holdings.

192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • IMC Chicago held 8,618 shares of Structure Therapeutics worth $463K as of Q2 2026.
  • Structure Therapeutics was a new IMC Chicago position in Q2 2026.
  • Structure Therapeutics made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #4740 holding.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.